ISOPP Education Collaborations
By choosing to partner with ISOPP, you become an integral part of our global oncology pharmacy community and your financial support will be used to progress ISOPP’s vision to advance oncology pharmacy care for all patients.
The International Society of Oncology Pharmacy Practitioners (ISOPP) advances oncology pharmacy care for patients throughout the world. Together we inspire the global oncology pharmacy community to take action, deliver enhanced professional development resources, and advocate for our profession out of a shared passion for helping cancer patients.
Your support will help over 3,500 oncology pharmacy practitioners around the world access valuable education and networking opportunities.
If you are interested in collaborating with ISOPP on educational materials or grants, please contact us at education@isopp.org.
ISOPP Education Collaborations
Oncology Pharmacotherapy and Applications of Biosimilars (OPAB) Program
Recognizing that there is a rapid expansion of Biosimilars usage in clinical practice, and that the role of an oncology pharmacist is evolving and further integrating as a key member of a multidisciplinary healthcare team, ISOPP developed the Oncology Pharmacotherapy and Applications of Biosimilars (OPAB) online education program that supports oncology pharmacists to safely and confidently introduce Biosimilars into their clinical practice and multidisciplinary healthcare team.
The Oncology Pharmacotherapy and Applications of Biosimilars (OPAB) Program is supported by Pfizer through an educational grant.
AstraZeneca Gulf and the Saudi Oncology Pharmacy Assembly (SOPA)
Building on past collaborations with AstraZeneca Gulf and the Saudi Oncology Pharmacy Assembly (SOPA), ISOPP presents the content for the Gulf Cooperation Council (GCC) Course Online Learning Series. This educational opportunity is geared to intermediate and experienced Clinical pharmacists specializing in oncology in Saudi Arabia, UAE and other Gulf countries. The seven-part series is an invitation-only scientific exchange forum for clinical pharmacists across the Gulf. The initiative aims to educate pharmacists on recent trends in oncology and international standards.
Past Events:
- Advancements and Ongoing Research & Managing Side Effects in the Treatment of HR+ve, HER2-ve Metastatic Breast Cancer (December 11, 2024)
- Early and Metastatic Non Small Cell Lung Cancer (NSCLC): Overview, Rationale and Management of Actionable Biomarkers and Optimal Immunotherapy Use (September 6, 2023)
- Evolving Role of HER2 Targeted Therapies and PARP Inhibitors in the Management of Breast Cancer (June 19, 2023)
UTIC
ISOPP (International Society of Oncology Pharmacy Practitioners) and BOPA (British Oncology Pharmacy Association) are pleased to announce this joint collaboration project – UTIC (Understanding targeted therapies and immunotherapies for cancer). It is a learning course over five modules taking you on a journey of learning and discovery about targeted therapies and immunotherapies used for the treatment of cancer. The videos can be set to have English subtitles.
This education program has been supported by a partial grant from Roche Products Limited and Incyte Biosciences UK Ltd. Roche Products Limited and Incyte Biosciences UK Ltd have had no control or influence over the educational content of this program.
Pharmacy Anti-cancer Drug (PAD) Course
The Pharmacy Anti-cancer Drug (PAD) Course supports pharmacists to develop the knowledge and clinical skills required to work safely with anti-cancer drugs and the patients receiving them. It has been brought to you in collaboration with eviQ Education, a program of the Cancer Institute NSW (Australia).